Keywords: Mitsubishi Tanabe, Anaphore, Autoimmune disorders. Novel proteins

Tanabe in $115 million R&D deal with Anaphore for novel protein drugs for autoimmune disorders

Article | 14 December 2010

Print This

Tanabe Research Laboratories (TRL), a US unit of Japan’s Mitsubishi Tanabe (4508: JP), has entered into a partnership with ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in